1 Min Read
May 9 (Reuters) - U.S. FDA:
* U.S. Food and Drug Administration grants accelerated approval to avelumab for urothelial carcinoma Source text (bit.ly/2pgHp8q) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.